Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance
This AASLD 2018 Hepatitis B Guidance is intended to complement the AASLD 2016
Practice Guidelines for Treatment of Chronic Hepatitis B (1) and update the previous …
Practice Guidelines for Treatment of Chronic Hepatitis B (1) and update the previous …
Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study
D Razavi-Shearer, I Gamkrelidze… - The lancet …, 2018 - thelancet.com
Summary Background The 69th World Health Assembly approved the Global Health Sector
Strategy to eliminate viral hepatitis by 2030. Although no virological cure exists for hepatitis …
Strategy to eliminate viral hepatitis by 2030. Although no virological cure exists for hepatitis …
Global prevalence, cascade of care, and prophylaxis coverage of hepatitis B in 2022: a modelling study
Summary Background The 2016 World Health Assembly endorsed the elimination of
hepatitis B virus (HBV) infection as a public health threat by 2030; existing therapies and …
hepatitis B virus (HBV) infection as a public health threat by 2030; existing therapies and …
[PDF][PDF] Chronic hepatitis B
ASF Lok, BJ McMahon - Hepatology, 2007 - Wiley Online Library
These guidelines have been written to assist physicians and other health care providers in
the recognition, diagnosis, and management of patients chronically infected with the …
the recognition, diagnosis, and management of patients chronically infected with the …
Chronic hepatitis B infection: a review
LSY Tang, E Covert, E Wilson, S Kottilil - Jama, 2018 - jamanetwork.com
Importance More than 240 million individuals worldwide are infected with chronic hepatitis B
virus (HBV). Among individuals with chronic HBV infection who are untreated, 15% to 40 …
virus (HBV). Among individuals with chronic HBV infection who are untreated, 15% to 40 …
Mechanisms of HBV-induced hepatocellular carcinoma
M Levrero, J Zucman-Rossi - Journal of hepatology, 2016 - Elsevier
Hepatitis B virus (HBV) contributes to hepatocellular carcinoma (HCC) development through
direct and indirect mechanisms. HBV DNA integration into the host genome occurs at early …
direct and indirect mechanisms. HBV DNA integration into the host genome occurs at early …
Natural history of chronic hepatitis B: special emphasis on disease progression and prognostic factors
G Fattovich, F Bortolotti, F Donato - Journal of hepatology, 2008 - Elsevier
The natural history of chronic hepatitis B virus (HBV) infection and disease is complex and
highly variable. We review the natural history of chronic hepatitis B with emphasis on the …
highly variable. We review the natural history of chronic hepatitis B with emphasis on the …
[PDF][PDF] The natural history of chronic hepatitis B virus infection
BJ McMahon - Hepatology, 2009 - Wiley Online Library
Chronic hepatitis B virus (HBV) infection has a complicated course. Three phases are
identified: an immune tolerant phase with high HBV DNA and normal alanine …
identified: an immune tolerant phase with high HBV DNA and normal alanine …
HBsAg seroclearance further reduces hepatocellular carcinoma risk after complete viral suppression with nucleos (t) ide analogues
Background & Aims In treated patients with chronic hepatitis B (CHB) who have achieved
complete viral suppression, it is unclear if functional cure as indicated by hepatitis B surface …
complete viral suppression, it is unclear if functional cure as indicated by hepatitis B surface …
Occult hepatitis B infection and hepatocellular carcinoma: Epidemiology, virology, hepatocarcinogenesis and clinical significance
Occult hepatitis B infection (OBI) refers to a condition where replication-competent HBV DNA
is present in the liver, with or without HBV DNA in the blood, in individuals with serum …
is present in the liver, with or without HBV DNA in the blood, in individuals with serum …